WallStreetZenWallStreetZen

NASDAQ: MRNS
Marinus Pharmaceuticals Inc Stock Ownership - Who owns Marinus Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Marinus Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Scott BraunsteinCHAIRMAN AND CEO2024-03-2750,000$4.28
$214.00kBuy
Martha E. ManningSVP GEN. COUNSEL CORP. SEC.2024-02-201,894$9.57
$18.13kSell
Christina ShaferCHIEF COMMERCIAL OFFICER2024-02-202,153$9.56
$20.58kSell
Joseph HulihanCHIEF MEDICAL OFFICER2024-02-162,814$9.98
$28.08kSell
Steven PfanstielCFO AND COO2024-02-163,092$9.97
$30.83kSell
Scott BraunsteinCHAIRMAN AND CEO2024-02-1611,850$9.94
$117.79kSell
Martha E. ManningSVP GEN. COUNSEL CORP. SEC.2023-08-0811$8.93
$98.23Sell
Scott BraunsteinCHAIRMAN AND CEO2023-08-0830$8.94
$268.20Sell
Joseph HulihanCHIEF MEDICAL OFFICER2023-08-0813$8.93
$116.09Sell
Steven PfanstielCFO AND COO2023-08-0814$8.93
$125.02Sell

1 of 2

MRNS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRNS insiders and whales buy or sell their stock.

MRNS Shareholders

What type of owners hold Marinus Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC9.78%5,346,119$7.70MInstitution
Blackrock Inc8.42%4,599,278$6.62MInstitution
Eventide Asset Management LLC8.29%4,529,997$6.52MInstitution
Bain Capital Life Sciences Investors LLC7.28%3,977,453$5.73MInsider
Franklin Resources Inc7.02%3,833,955$5.52MInstitution
Cormorant Asset Management LP5.95%3,250,000$4.68MInstitution
Avoro Capital Advisors LLC5.76%3,150,000$4.54MInstitution
Jennison Associates LLC5.42%2,959,161$4.26MInstitution
Vanguard Group Inc4.89%2,673,231$3.85MInstitution
Adage Capital Partners GP LLC4.72%2,581,250$3.72MInstitution

1 of 3

MRNS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRNS81.93%18.07%Net BuyingNet Buying
VTVT0.11%99.89%Net BuyingNet Buying
TPST4.15%95.85%
SPRO25.60%64.13%Net SellingNet Selling
CMRX45.42%31.91%Net BuyingNet Selling
View Top Biotech Stocks

Marinus Pharmaceuticals Stock Ownership FAQ

Who owns Marinus Pharmaceuticals?

Marinus Pharmaceuticals (NASDAQ: MRNS) is owned by 98.53% institutional shareholders, 21.74% Marinus Pharmaceuticals insiders, and 0.00% retail investors. Bain Capital Life Sciences Investors LLC is the largest individual Marinus Pharmaceuticals shareholder, owning 3.98M shares representing 7.28% of the company. Bain Capital Life Sciences Investors LLC's Marinus Pharmaceuticals shares are currently valued at $5.65M.

If you're new to stock investing, here's how to buy Marinus Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.